Stocks and Investing Stocks and Investing
Wed, March 25, 2020
Tue, March 24, 2020

Mani Foroohar Upgraded (ARWR) to Hold on, Mar 24th, 2020


Published on 2024-10-27 00:53:10 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Upgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Hold on, Mar 24th, 2020.

Mani has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 3 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, March 17th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $55 on, Thursday, February 6th, 2020
  • Esther Rajavelu of "Oppenheimer" Initiated at Hold on, Friday, December 13th, 2019


These are the ratings of the 2 analyists that currently disagree with Mani


  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $57 on, Friday, March 13th, 2020
  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Increased Target to $70 on, Monday, November 25th, 2019
Contributing Sources